EUVIMEDEUVIMED entdecken
Crossref

Enhanced Antitumor Efficacy and Reduced Myelosuppression by a Supramolecular Complex Composed of Azocalix[4]arene and Sunitinib

Jing Liu iD, Fangqian Yin iD, Yanbin Ren, Mengqiong Ming, Houhuan Xie, Xin Cai, Juan-Juan Li, Dong-Sheng Guo iD, Ke-Rang Wang iD

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.5c02487 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Jing Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Materials Science, State Key Laboratory of New Pharmaceutical Preparations and Excipients, Key Laboratory of Medicinal Chemi…. Hauptthemen laut MEDLINE: Calixarenes, Sunitinib, Antineoplastic Agents, Angiogenesis Inhibitors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Department of Education of Hebei Province, Natural Science Foundation of Hebei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antiangiogenic therapy, which inhibits tumor growth by blocking oxygen and nutrition supply, represents a promising strategy for antineoplastic therapy. However, the widespread biodistribution of antiangiogenic agents often leads to off-target toxicities, including hematotoxicity and myelosuppression. In this study, we demonstrated that the sunitinib@mannose-modified azocalix[4]arene (ST@ManAC4A) complex exhibited favorable tumor-targeting capabilities, hypoxia-responsive drug release, and effective accumulation at the tumor site, thus enhancing antiproliferative efficacy while alleviating thrombocytopenia and myelosuppression. The complex exhibited robust antitumor activity in both cellular and in vivo assays. Additionally, histopathological, immunohistochemical, and bone marrow analyses demonstrated that ST@ManAC4A enhanced antiproliferation, apoptosis, and antiangiogenesis while alleviating thrombocytopenia and platelet-related myelosuppression. These findings underscore the potential of the mannose-modified supramolecular host–guest complex as a versatile form for improving chemotherapy outcomes. By enabling efficient drug loading and precision targeting, this approach offers a promising strategy to enhance therapeutic efficacy while minimizing off-target toxicities, addressing a critical challenge in cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CalixarenesSunitinibAntineoplastic AgentsAngiogenesis InhibitorsAnimalsHumansMiceApoptosisCell ProliferationCell Line, TumorThrombocytopeniaMice, Inbred BALB CMice, Nude

Substanzen

CalixarenesSunitinibAntineoplastic AgentsAngiogenesis Inhibitors

Autor:innen und Institutionen

  • College of Chemistry and Materials Science, State Key Laboratory of New Pharmaceutical Preparations and Excipients, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis (Ministry of Education), Key Laboratory o…
  • College of Veterinary Medicine/Chinese Veterinary Medicine, Hebei Agricultural University, Baoding 071000, P. R. China.
  • College of Chemistry, State Key Laboratory of Elemento-Organic Chemistry, Key Laboratory of Functional Polymer Materials (Ministry of Education), Frontiers Science Center for New Organic Matter, Collaborative Innovation…

ORCID-Profile: Jing Liu, Fangqian Yin, Dong-Sheng Guo, Ke-Rang Wang

Förderung

  • National Natural Science Foundation of China
  • Department of Education of Hebei Province
  • Natural Science Foundation of Hebei Province
  • Hebei University
  • Foundation of Hebei University

Zitieren

APA

Liu, J., Yin, F., Ren, Y., Ming, M., Xie, H., Cai, X., Li, J. J., Guo, D. S., & Wang, K. R. (2025). Enhanced Antitumor Efficacy and Reduced Myelosuppression by a Supramolecular Complex Composed of Azocalix[4]arene and Sunitinib. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c02487

Vancouver

Liu J, Yin F, Ren Y, Ming M, Xie H, Cai X, et al. Enhanced Antitumor Efficacy and Reduced Myelosuppression by a Supramolecular Complex Composed of Azocalix[4]arene and Sunitinib. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.5c02487

BibTeX
@article{Liu2025,
  author = {Liu, Jing and Yin, Fangqian and Ren, Yanbin and Ming, Mengqiong and Xie, Houhuan and Cai, Xin and Li, Juan-Juan and Guo, Dong-Sheng and Wang, Ke-Rang},
  title = {Enhanced Antitumor Efficacy and Reduced Myelosuppression by a Supramolecular Complex Composed of Azocalix[4]arene and Sunitinib},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.5c02487}
}
Kostenlos starten →